All News

Strategy

Autologous vs Allogeneic: What Therapeutic Developers and Manufacturers Really Need to Know
16 March 2023
Autologous vs Allogeneic: What Therapeutic Developers and Manufacturers Really Need to Know
Rupa Pike, Senior Director of
Early Adoption and Partnerships – The Secret to Commercialization Success?
2 March 2023
Early Adoption and Partnerships – The Secret to Commercialization Success?
This Briefing from Advanced Therapies
Top 10 Events in Cell & Gene Therapy 2022
18 January 2023
Top 10 Events in Cell & Gene Therapy 2022
It’s day 1 of Advanced
The Advanced Therapies Workforce Evolution
29 November 2022
The Advanced Therapies Workforce Evolution
For this interview, Phacilitate’s Becky
POPULAR NEWS ITEMS
Image
23 March 2023

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers

Image
14 March 2023

Pfizer Invests $43 Billion to Acquire Seagen

Image
2 March 2023

Early Adoption and Partnerships – The Secret to Commercialization Success?

Setting the Stage for Successful Clinical Manufacturing of Cell and Gene Therapies
18 October 2022
Setting the Stage for Successful Clinical Manufacturing of Cell and Gene Therapies
Are you preparing to advance
Market Access and Reimbursement Q&A with AviadoBio CEO Lisa Deschamps
21 June 2022
Market Access and Reimbursement Q&A with AviadoBio CEO Lisa Deschamps
Lisa Deschamps, AviadoBio CEO and
Market Access and Reimbursement Q&A with Nicola Redfern
21 June 2022
Market Access and Reimbursement Q&A with Nicola Redfern
Phacilitate's Advanced Therapies Europe speaker
Industrializing the Next Generation of Cell and Gene Therapies
20 June 2022
Industrializing the Next Generation of Cell and Gene Therapies
In this webinar, discover how
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers

Image

Pfizer Invests $43 Billion to Acquire Seagen

Image

Early Adoption and Partnerships – The Secret to Commercialization Success?